Myrsini Chamakioti

Ms. Myrsini Chamakioti

University of Patras, Pátrai, Greece
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MCMyrsini Chamakioti
Myrsini Chamakioti
George P. ChrousosGeorge P. Chrousos
George P. Chrousos
EKEva Kassi
Eva Kassi
Dimitrios P VlachakisDimitrios P Vlachakis
Dimitrios P Vlachakis
CYChristos Yapijakis
Christos Yapijakis
Exosomes, natural nanovesicles that contain a cargo of biologically active molecules such as lipids, proteins, and nucleic acids, are released from cells to the extracellular environment. They then act as autocrine, paracrine, or endocrine mediators of communication between cells by delivering their cargo into recipient cells and causing downstream effects. Exosomes are greatly enriched in miRNAs, which are small non-coding RNAs that act both as cytoplasmic post-transcriptional repression agents, modulating the translation of mRNAs into proteins, as well as nuclear transcriptional gene activators. Neuronal exosomal miRNAs have important physiologic functions in the central nervous system (CNS), including cell-to-cell communication, synaptic plasticity, and neurogenesis, as well as modulating stress and inflammatory responses. Stress-induced changes in exosomal functions include effects on neurogenesis and neuroinflammation, which can lead to the appearance of various neuropsychiatric disorders such as schizophrenia, major depression, bipolar disorder, and Alzheimer’s and Huntington’s diseases. The current knowledge regarding the roles of exosomes in the pathophysiology of common mental disorders is discussed in this review.

Verified
Journal Article
Open access
PDF file
MCMyrsini Chamakioti
Myrsini Chamakioti
NKNikolaos Karantzelis
Nikolaos Karantzelis
Stavros TaravirasStavros Taraviras
Stavros Taraviras
Gene therapy is a revolutionary, cutting-edge approach to permanently ameliorate or amend many neuromuscular diseases by targeting their genetic origins. Motor neuron diseases and muscular dystrophies, whose genetic causes are well known, are the frontiers of this research revolution. Several genetic treatments, with diverse mechanisms of action and delivery methods, have been approved during the past decade and have demonstrated remarkable results. However, despite the high number of genetic treatments studied preclinically, those that have been advanced to clinical trials are significantly fewer. The most clinically advanced treatments include adeno-associated virus gene replacement therapy, antisense oligonucleotides, and RNA interference. This review provides a comprehensive overview of the advanced gene therapies for motor neuron diseases (i.e., amyotrophic lateral sclerosis and spinal muscular atrophy) and muscular dystrophies (i.e., Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and myotonic dystrophy) tested in clinical trials. Emphasis has been placed on those methods that are a few steps away from their authoritative approval.

8 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CYChristos Yapijakis
Christos Yapijakis
IGIphigenia Gintoni
Iphigenia Gintoni
MCMyrsini Chamakioti
Myrsini Chamakioti
EKEleni Koniari
Eleni Koniari
EPEleni E Papanikolaou
Eleni E Papanikolaou
George P. ChrousosGeorge P. Chrousos
George P. Chrousos
Background: Osteodysplastic syndromes compose a very diverse group of clinically and genetically heterogeneous disorders characterized by defects in bone and connective tissue development, as well as in bone density. Here, we report the case of a 48-year-old female with a complex medical history characterized by bone dysplasia, hyperostosis, and partial tooth agenesis. Methods: Genetic testing was performed using WES analysis and Sanger sequencing. Molecular modeling analysis and dynamics simulation explored the impact of detected pathogenic variants. Results: The genetic analysis detected multiple pathogenic variants in genes CREB3L1, SLCO2A1, SFRP4, LRP5 and LRP6, which are associated with rare osteodysplastic syndromes. The patient was homozygous for the same rare alleles associated with three of the identified autosomal recessive disorders, such as osteogenesis imperfecta type XVI, primary hypertrophic osteoarthropathy, and metaphyseal dysplasia Pyle type. She also had a variant linked to autosomal dominant endosteal hyperostosis and a variant previously associated with increased risk of osteoporosis and fractures. Two of the detected variants are predicted to cause abnormal splicing, while molecular modelling and dynamics simulations analysis suggest that the other three variants probably confer altered local secondary structure and flexibility that may be functionally devastating consequences. Conclusions: Our case highlights the rare coexistence of multiple osteodysplastic syndromes in a single patient that may complicate differential diagnosis. Furthermore, this case emphasizes the necessity for early genetic investigation of such complex cases with overlying phenotypic traits, followed by genetic counseling, in order to orchestrate clinical interventions and prevent or promptly manage manifestations.

23 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
NZNickolas Ziakas
Nickolas Ziakas
MCMyrsini Chamakioti
Myrsini Chamakioti
IGIphigenia Gintoni
Iphigenia Gintoni
DHDemetrios J. Halazonetis
Demetrios J. Halazonetis
George P. ChrousosGeorge P. Chrousos
George P. Chrousos
CYChristos Yapijakis
Christos Yapijakis
Background: Tall stature is a multifactorial phenotypic trait encountered in the general pediatric population; however, it could constitute a manifestation of an underlying genetic and/or endocrine disorder. Mutations in genes involved in gene transcription, genomic imprinting and intracellular vesicle trafficking may lead to dysregulation of certain cellular pathways associated with different genetic syndromes with overgrowth and tall stature. Objective: Considering the facial changes that growth hormone surplus induces, it would be reasonable to hypothesize that the maxillofacial phenotype is also affected in certain genetic conditions causing excessive linear growth. The aim of this review is to assess the cephalometric data for certain genetic and/or endocrine diseases causing tall stature and overgrowth in children and discuss the potential role of cephalometric analysis in diagnosis of such phenotypes and better understanding of the underlying causing molecular mechanisms. Design: A literature search was conducted in the PubMed electronic database. The scientific articles that provided cephalometric data for genetic syndromes and conditions associated with tall stature or overgrowth were included. The following keywords were utilized: tall stature cephalometry, overgrowth syndromes cephalometry, gigantism cephalometry, hemihyperplasia cephalometric, hemihypertrophy cephalometric, Simpson–Golabi–Behmel cephalometric, Prader–Willi cephalometry, and Marfan and Klinefelter cephalometry. Results: Although the number of studies found remains limited (n = 37), the consensus findings indicate that the growth of the craniofacial complex of patients with genetic syndromes causing tall stature is affected. The cephalometric measurements assessing the cranial base, the jaws and the facial soft tissue differ from the norm and are suggestive of irregularities in both the sagittal and vertical planes. Conclusions: As the literature in this field is particularly rare, more data are required to establish relations between excessive linear growth and the maxillofacial phenotype exhibited in certain genetic and/or endocrine syndromes. Nevertheless, lateral cephalometric radiography is an extensively utilized imaging method that could potentially serve as a promising tool in the early diagnosis, phenotype–genotype comparative research and better understanding of the underlying causing molecular mechanisms of conditions associated with tall stature.

24 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MCMyrsini Chamakioti
Myrsini Chamakioti
George P. ChrousosGeorge P. Chrousos
George P. Chrousos
EKEva Kassi
Eva Kassi
Dimitrios P VlachakisDimitrios P Vlachakis
Dimitrios P Vlachakis
CYChristos Yapijakis
Christos Yapijakis
Exosomes, natural nanovesicles that contain a cargo of biologically active molecules such as lipids, proteins, and nucleic acids, are released from cells to the extracellular environment. They then act as autocrine, paracrine, or endocrine mediators of communication between cells by delivering their cargo into recipient cells and causing downstream effects. Exosomes are greatly enriched in miRNAs, which are small non-coding RNAs that act as cytoplasmic posttranscriptional repression agents, modulating the translation of mRNAs into proteins, as well as nuclear transcriptional gene activators. Neuronal exosomal miRNAs have important physiologic functions in the Central Nervous System (CNS), including cell-to-cell communication, synaptic plasticity, and neurogenesis, as well as modulating stress and inflammatory responses. Stress-induced changes of exosomal functions include effects on neurogenesis and neuroinflammation, which can lead to the appearance of various neuropsychiatric disorders, such as schizophrenia, major depression, bipolar disorder, and Alzheimer's and Huntington’s's diseases. The current knowledge regarding the roles of exosomes in the pathophysiology of common mental disorders is discussed in this review.

24 July 2025 in Genes
Verified
Journal Article
Open access
PDF file
CYChristos Yapijakis
Christos Yapijakis
IGIphigenia Gintoni
Iphigenia Gintoni
MCMyrsini Chamakioti
Myrsini Chamakioti
EKEleni Koniari
Eleni Koniari
EPEleni E Papanikolaou
Eleni E Papanikolaou
George P. ChrousosGeorge P. Chrousos
George P. Chrousos
Background: Osteodysplastic syndromes comprise a very diverse group of clinically and genetically heterogeneous disorders characterized by defects in bone and connective tissue development, as well as in bone density. Here, we report the case of a 48-year-old female with a complex medical history characterized by bone dysplasia, hyperostosis, and partial tooth agenesis. Methods: Genetic testing was performed using WES analysis and Sanger sequencing. Molecular modeling analysis and dynamics simulation explored the impact of detected pathogenic variants. Results: The genetic analysis detected multiple pathogenic variants in genes CREB3L1, SLCO2A1, SFRP4, LRP5, and LRP6, each of which has been associated with rare osteodysplastic syndromes. The patient was homozygous for the same rare alleles associated with three of the identified autosomal recessive disorders osteogenesis imperfecta type XVI, primary hypertrophic osteoarthropathy, and metaphyseal dysplasia Pyle type. She also had a variant linked to autosomal dominant endosteal hyperostosis and a variant previously associated with increased risk of osteoporosis and bone fractures. Two of the detected variants are predicted to cause abnormal splicing, while molecular modeling and dynamics simulations analysis suggest that the other three variants probably confer altered local secondary structure and flexibility that may have functionally devastating consequences. Conclusions: Our case highlights the rare coexistence of multiple osteodysplastic syndromes in a single patient that may complicate differential diagnosis. Furthermore, this case emphasizes the necessity for early genetic investigation of such complex cases with overlying phenotypic traits, followed by genetic counseling, facilitating orchestration of clinical interventions and allowing prevention and/or prompt management of manifestations.